Free Trial
NYSEARCA:PSIL

AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News

$0.80
-0.01 (-1.23%)
(As of 09/6/2024 ET)
Today's Range
$0.80
$0.82
50-Day Range
$0.80
$1.11
52-Week Range
$0.80
$1.82
Volume
64,666 shs
Average Volume
62,061 shs
Market Capitalization
$4.50 million
Assets Under Management
$4.70 million
Dividend Yield
6.24%
Net Expense Ratio
0.99%
PSIL stock logo

About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL)

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.

PSIL Stock Price History

PSIL ETF News Headlines

AdvisorShares Announces Reverse Split of ETF
AdvisorShares Psychedelics ETF
Biden's Successor: The Radical Threat to YOUR Savings!
Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.
Biden's Successor: The Radical Threat to YOUR Savings!
Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.
See More Headlines
Receive PSIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
AdvisorShares
Fund Name
AdvisorShares Psychedelics ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:PSIL
Inception Date
9/15/2021
Fund Manager
Dan S. Ahrens
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
28

Fund Statistics

Assets Under Management
$4.70 million
Average Daily Volume
$0.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
AdvisorShares Investments, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
15
Put Options
35
Call Options
15
Short Interest
298,200 shs

Miscellaneous

Beta
0.87
Creation Fee
$500.00
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

AdvisorShares Psychedelics ETF Expenses

TypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.60%0.57%0.55%0.51%0.52%
Other Expenses2.41%0.57%0.49%0.58%0.54%
Total Expense3.01%0.73%0.71%0.74%0.71%
Fee Waiver-2.02%-0.74%-0.53%-0.68%-0.58%
Net Expense0.99%0.59%0.61%0.58%0.59%

AdvisorShares Psychedelics ETF (PSIL) Holdings & Exposure

PSIL Sector Exposure

PSIL Industry Exposure


PSIL ETF - Frequently Asked Questions

How have PSIL shares performed this year?

AdvisorShares Psychedelics ETF's stock was trading at $1.39 at the beginning of 2024. Since then, PSIL stock has decreased by 42.3% and is now trading at $0.8015.
View the best growth stocks for 2024 here
.

How do I buy shares of AdvisorShares Psychedelics ETF?

Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:PSIL) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners